Study Stopped
Study was withdrawn due to PI decision
Transoral Gastric Volume Reduction as an Intervention for Weight Management
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study assesses weight loss from the Endoscopic Vertical Gastroplasty or Fogel Gastroplasty (FG). The purpose of the study is to:
- Document that weight loss occurs (12 months)
- Determine if it alters general wellbeing (emotionally and physically)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2015
CompletedFirst Posted
Study publicly available on registry
October 19, 2015
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2018
CompletedAugust 31, 2017
May 1, 2017
7 months
October 15, 2015
August 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Loss
12 months
Secondary Outcomes (4)
Emotional Wellbeing
12 months
Change in blood pressure
baseline to 12 months
Change in cholesterol level
baseline to 12 months
Change in glucose levels
baseline to 12 months
Study Arms (1)
Fogel Gastroplasty
EXPERIMENTALThe subject will be placed under general anesthesia. The procedure will last approximately 1-2 hours. CO2 will be used rather than air for the insufflation that is required during the procedure to minimize abdominal distention. The physician will place an interrupted suture pattern in a manner which partitions the greater curvature of the stomach from the Angle of His to the level of the incisura, creating a tube-like passage for gastric volume reduction. Afterwards, the remaining gastric volume will be reduced using a circumferential running stitch.The device that will be used to place the stitches is the OverStitch system FDA approved for tissue apposition
Interventions
The subject will be placed under general anesthesia. The procedure will last approximately 1-2 hours. CO2 will be used rather than air for the insufflation that is required during the procedure to minimize abdominal distention. The physician will place an interrupted suture pattern in a manner which partitions the greater curvature of the stomach from the Angle of His to the level of the incisura, creating a tube-like passage for gastric volume reduction. Afterwards, the remaining gastric volume will be reduced using a circumferential running stitch.The device that will be used to place the stitches is the OverStitch system FDA approved for tissue apposition
Eligibility Criteria
You may qualify if:
- Subject is ≥ 18 yrs. of age and ≤ 60 yrs. of age
- Subject has a BMI between 28 and 34.9
- Subject is willing to complete all follow-up visits after procedure ( 3, 6 and 12 months)
You may not qualify if:
- Patients that are not willing to participate in the study
- Patients with history of Gastrointestinal tumors, Gastric Cancer, previous bariatric, gastric or esophageal surgery; intestinal obstruction; portal gastropathy, esophageal or gastric varices, or gastroparesis,
- Subject has significant esophageal disease including Zenker's diverticulum, grade 3-4 reflux esophagitis, stricture, Barrett's esophagus, esophageal cancer, esophageal diverticulum, dysphagia, achalasia, or symptoms of dysmotility or Hiatal Hernia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami Clinical Research Building
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Fogel, MD
University of Miami
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 15, 2015
First Posted
October 19, 2015
Study Start
August 1, 2017
Primary Completion
March 1, 2018
Study Completion
November 1, 2018
Last Updated
August 31, 2017
Record last verified: 2017-05